Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Humana Inc (HUM) vs iShares Core MSCI EAFE ETF (IEFA) Price & Performance

Humana IncTrade
iShares Core MSCI EAFE ETFTrade

Price performance (Past 24H)

Key statistics

Humana Inc vs iShares Core MSCI EAFE ETF — how do they compare? Humana Inc trades at $437.41 (market cap $47.61B), while iShares Core MSCI EAFE ETF trades at $95.89 (market cap $191.47B). The key difference: iShares Core MSCI EAFE ETF is far larger — about 4× Humana Inc's market cap, and Humana Inc pays a 0.89% dividend while iShares Core MSCI EAFE ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and iShares Core MSCI EAFE ETF for 41 Days on average.

HUMIEFA
Market Cap
$47.61B$191.47B
Volume
1,827,33211,673,895
Sector
HealthBroad Market / Factor
52-Week High
$409.85$101.41
52-Week Low
$163.67$85.06
Typical Hold Time
53 Days41 Days
Enterprise Value
$54.97B—
Dividend Yield
0.89%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Humana Inc

Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.

Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.

iShares Core MSCI EAFE ETF

IEFA (iShares Core MSCI EAFE ETF) trades at $96.20, down 1.08% with bearish technical signals from moving averages but neutral oscillators. The ETF provides exposure to developed markets outside North America with $196 billion in assets under management. Recent comparisons highlight its competitive expense ratio of 0.07% and higher dividend yield versus peers like Schwab's SCHF and State Street's SPDW.

The fund faces headwinds from international market volatility and currency risks, though its size and diversification offer stability. Near-term performance may be influenced by global economic conditions and investor rotation away from concentrated U.S. tech exposure. Key support sits at $95 with resistance at $97.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HUM

No sentiment data available yet.

IEFA
100% Buy0% Sell
Avg holding period · 41 Days

Top news

Latest headlines on both assets

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM →

About iShares Core MSCI EAFE ETF

IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.

Read more on IEFA →